Vancomycin-resistant entrococcal colonisation of hospitalised patients in Auckland

New Zealand Medical Journal

Volumn 115, Issue 1160, 2002, Pages

  Briggs, Simon ^a   Upton, Arlo ^b   Bilkey, Mary ^a   Taylor, Susan ^b   Roberts, Sally ^a   Holland, David ^a  

^a AUCKLAND CITY HOSPITAL   (New Zealand)

^b MIDDLEMORE HOSPITAL   (New Zealand)

Author keywords

[No Author keywords available]

Indexed keywords

AMPICILLIN; VANCOMYCIN;

ADOLESCENT; ADULT; AGED; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; AWARENESS; BACTERIAL COLONIZATION; BACTERIAL TRANSMISSION; BACTERIUM CULTURE; BACTERIUM ISOLATE; BACTERIUM ISOLATION; BIOASSAY; CHILD; CLOSTRIDIUM DIFFICILE; CONTROLLED STUDY; ENTEROCOCCUS FAECALIS; FECES ANALYSIS; FEMALE; GENOTYPE; HEALTH CARE PLANNING; HOSPITAL INFECTION; HOSPITAL MANAGEMENT; HOSPITAL PATIENT; HUMAN; INFANT; INFECTION PREVENTION; MAJOR CLINICAL STUDY; MALE; NEW ZEALAND; NEWBORN; PREVALENCE; VANCOMYCIN RESISTANT ENTEROCOCCUS;

EID: 25844462853     PISSN: 11758716     EISSN: 11758716     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. Uttley AH, Collins CH, Naidoo J, George RC. Vancomycin-resistant enterococci. Lancet 1988;1:57-8.
2. Leclercq R, Derlot E, Duval J, Courvalin P. Plasmid-mediated resistance to vancomycin and teicoplanin in Enterococcus faecium. N Eng J Med 1988;319:157-61.
3. National Nosocomial Infections Surveillance (NNIS) System Report, data summary from January 1992-June2001, issued August 2001. Available at www.cdc.gov/ncidod/hip/NNIS/members/2001NNIS report
4. Centers for Disease Control and Prevention. Recommendations for preventing the spread of vancomycin resistance. MMWR 1995;44 No RR-12:1-13.
5. Hayden MK. Insights into the epidemiology and control of infection with vancomycin-resistant enterococci. Clin Infect Dis 2000;31:1058-65.
6. McDonald LC, Kuehnert MJ, Tenover FC, Jarvis WR. Vancomycin-resistant enterococci outside the health-care setting: prevalence, sources and public health implications. Emerg Infect Dis 1997;3:311-7.
7. Cetinkaya Y, Falk P, Mayhall CG. Vancomycin-resistant enterococci. Clin Microbiol Rev 2000;13:686-707.
8. Taylor SL, Pottumarthy S, Wong CG et al. Surveillance for antimicrobial resistance in enterococci. NZ Med J 1997;110:251-3.
9. Kobayashi K, Rao M, Keis S et al. Enterococci with reduced susceptibility to vancomycin in New Zealand. J Antimicrob Chemother 2000;46:405-10.
10. Ostrowsky BE, Trick WE, Sohn AH et al. Control of vancomycin-resistant enterococcus in health care facilities in a region. N Engl J Med 2001;344: 1427-33.
11. Hacek DM, Bednarz P, Noskin et al. Yield of vancomycin-resistant enterococci and multidrug-resistant Enterobacteriaceae from stools submitted for Clostridium difficile testing compared to results from a focused surveillance program. J Clin Microbiol 2001;39:1152-54.
12. Gerding DN. Is there a relationship between vancomycin-resistant enterococcal infection and Clostridium difficile infection? Clin Infect Dis 1997;25:S206-10.
13. Endtz HP, van den Braak N, van Belkum A et al. Faecal carriage of vancomycin-resistant enterococci in hospitalised patients and those living in the community in the Netherlands. J Clin Microbiol 1997;35:3026-31.
14. Wegener HC, Aarestrup FM, Jensen LB et al. Use of antimicrobial growth promoters in food animals and Enterococcus faecium resistant to therapeutic antimicrobial drugs in Europe. Emerg Infect Dis 1999;5:329-35.